Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes. Circulation. 2019 11 05; 140(19):1578-1589.

View in: PubMed

subject areas

Acute Coronary Syndrome
Aged
American Heart Association
Antibodies, Monoclonal, Humanized
Anticholesteremic Agents
Biomarkers
Cholesterol
Dyslipidemias
Female
Humans
Male
Middle Aged
Practice Guidelines as Topic
Proprotein Convertase 9
Recurrence
Risk Assessment
Risk Factors
Secondary Prevention
Serine Proteinase Inhibitors
Time Factors
Treatment Outcome
United States

authors with profiles

Robert Harrington